Elixinol Wellness Expands Product Offering with Vitable Acquisition
Elixinol to acquire Vitable via all-scrip deal, adding subscription revenue and personalised tech; targets $27m revenue and $3m EBITDA by 2028; stock in focus.
Elixinol to acquire Vitable via all-scrip deal, adding subscription revenue and personalised tech; targets $27m revenue and $3m EBITDA by 2028; stock in focus.